We previously showed in breast cancer cells expressing CCT2-FLAG that ~70% of the CCT2-FLAG protein was incorporated into the CCT hetero-oligomeric complex and ~30% remained as an unincorporated monomer (7, 8). This evidence concerns the gene FLVCR2 and breast carcinoma.